메뉴 건너뛰기




Volumn 67, Issue 12, 2008, Pages 1791-1792

A polymorphism in the gene encoding the Fcγ IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FC GAMMA R III A; INFLIXIMAB; UNCLASSIFIED DRUG;

EID: 56749168819     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2007.086892     Document Type: Letter
Times cited : (16)

References (4)
  • 1
    • 25444478561 scopus 로고    scopus 로고
    • Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents
    • Tutuncu Z, Kavanaugh A, Zvaifler N, Corr M, Deutsch R, Boyle D. Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents. Arthritis Rheum 2005;52:2693-6.
    • (2005) Arthritis Rheum , vol.52 , pp. 2693-2696
    • Tutuncu, Z.1    Kavanaugh, A.2    Zvaifler, N.3    Corr, M.4    Deutsch, R.5    Boyle, D.6
  • 2
    • 0030611089 scopus 로고    scopus 로고
    • A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease
    • Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059- 70.
    • (1997) J Clin Invest , vol.100 , pp. 1059-1070
    • Wu, J.1    Edberg, J.C.2    Redecha, P.B.3    Bansal, V.4    Guyre, P.M.5    Coleman, K.6
  • 3
    • 33847044755 scopus 로고    scopus 로고
    • Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis
    • Kastbom A, Bratt J, Ernestam S, Lampa J, Padyukov L, Soderkvist P, et al. Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:448-52.
    • (2007) Arthritis Rheum , vol.56 , pp. 448-452
    • Kastbom, A.1    Bratt, J.2    Ernestam, S.3    Lampa, J.4    Padyukov, L.5    Soderkvist, P.6
  • 4
    • 33751108526 scopus 로고    scopus 로고
    • Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: A subanalysis of the ACCENT I study
    • Louis EJ, Watier HE, Schreiber S, Hampe J, Taillard F, Olson A, et al. Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study. Pharmacogenet Genomics 2006;16:911-14.
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 911-914
    • Louis, E.J.1    Watier, H.E.2    Schreiber, S.3    Hampe, J.4    Taillard, F.5    Olson, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.